Home › NDC Lookup › RxCUI directory › RxCUI 979466

Hydrochlorothiazide 12.5 MG / losartan potassium 100 MG Oral Tablet [Hyzaar] — RxCUI 979466

RxNorm drug concept · Semantic branded drug
RxCUI 979466 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI979466
Official nameHydrochlorothiazide 12.5 MG / losartan potassium 100 MG Oral Tablet [Hyzaar]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asHyzaar 100/12.5 Oral Tablet; Hyzaar 100 MG / 12.5 MG Oral Tablet; HCTZ 12.5 MG / Losartan K+ 100 MG Oral Tablet [Hyzaar]; HCTZ 12.5 MG / Losartan Pot 100 MG Oral Tablet [Hyzaar]
FDA products mapped3
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hydrochlorothiazide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It lowers high blood pressure, which helps reduce the risk of strokes and heart attacks. Some products, such as Inzirqo and the tablets, are also used for swelling from conditions...
  • Take it by mouth exactly as prescribed, usually once a day. For swelling, your prescriber may have you take it only some days of the week. Food slightly lowers absorption, so ask m...
  • Dizziness, lightheadedness when standing, stomach upset, headache and weakness are the usual ones. Stand up slowly, and be careful with alcohol since it can worsen dizziness. Use s...
  • Call for eye pain or sudden vision changes, severe rash or blistering, trouble breathing, severe stomach pain, yellow skin or eyes, or unusual bruising or infections. Also call for...
📖 Read our full Hydrochlorothiazide guide →

🕸️ Concept Web — How Hydrochlorothiazide 12.5 MG / losartan potassium... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Hydrochlorothiazide 12.5 MG / losartan potassium 100 MG Oral Tablet [Hyzaar] RxCUI 979466

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Hydrochlorothiazide 5487
    • Losartan 52175
    • Hydrochlorothiazide / losartan 214619
    • Losartan potassium 203160
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Hyzaar 217681
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Hydrochlorothiazide / losartan Oral Tablet 372650
    • Hydrochlorothiazide / losartan potassium Oral Tablet 2649054
    • Hydrochlorothiazide / losartan Oral Product 1162126
    • Hydrochlorothiazide / losartan Pill 1162127
    • Hydrochlorothiazide / losartan potassium Oral Product 2661112
    • Hydrochlorothiazide / losartan potassium Pill 2663661
    • Hydrochlorothiazide / losartan Oral Tablet [Hyzaar] 823962
    • Hydrochlorothiazide / losartan potassium Oral Tablet [Hyzaar] 2658550
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Hydrochlorothiazide 12.5 MG / losartan potassium 100 MG Oral Tablet SCD · 979464
  • Hydrochlorothiazide 12.5 MG SCDC · 316047
  • Losartan potassium 100 MG SCDC · 979463
  • Hydrochlorothiazide / losartan Oral Tablet SCDF · 372650
  • Hydrochlorothiazide / losartan potassium Oral Tablet SCDFP · 2649054
  • Hydrochlorothiazide / losartan Oral Product SCDG · 1162126
  • Hydrochlorothiazide / losartan Pill SCDG · 1162127
  • Hydrochlorothiazide / losartan potassium Oral Product SCDGP · 2661112
  • Hydrochlorothiazide / losartan potassium Pill SCDGP · 2663661

Brand-Name Concepts

  • Hydrochlorothiazide 12.5 MG / losartan potassium 100 MG [Hyzaar] SBDC · 979465
  • Hydrochlorothiazide / losartan Oral Tablet [Hyzaar] SBDF · 823962
  • Hydrochlorothiazide / losartan potassium Oral Tablet [Hyzaar] SBDFP · 2658550
  • Hyzaar Oral Product SBDG · 1166546
  • Hyzaar Pill SBDG · 1166549
  • Hyzaar BN · 217681

📦 FDA Products & Package NDCs

3 products · 6 package NDCs
6 package NDCs map to RxCUI 979466 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
78206-0139-01 30 TABLET, FILM COATED in 1 BOTTLE (78206-139-01) HYZAAR Organon LLC 2021-06-01
78206-0139-02 90 TABLET, FILM COATED in 1 BOTTLE (78206-139-02) HYZAAR Organon LLC 2021-06-01
78206-0140-01 30 TABLET, FILM COATED in 1 BOTTLE (78206-140-01) HYZAAR Organon LLC 2021-06-01
78206-0140-02 90 TABLET, FILM COATED in 1 BOTTLE (78206-140-02) HYZAAR Organon LLC 2021-06-01
78206-0141-01 30 TABLET, FILM COATED in 1 BOTTLE (78206-141-01) HYZAAR Organon LLC 2021-06-01
78206-0141-02 90 TABLET, FILM COATED in 1 BOTTLE (78206-141-02) HYZAAR Organon LLC 2021-06-01
Observed labelers: Organon LLC (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.